Showing 1 - 3 results of 3 for search 'M.J. van Dijk', query time: 0.02s Refine Results
  1. 1
    P1065: CONGENITAL ERYTHROCYTOSIS DUE TO HETEROZYGOUS VARIANTS IN THE BISPHOSPHOGLYCERATE MUTASE GENE

    P1065: CONGENITAL ERYTHROCYTOSIS DUE TO HETEROZYGOUS VARIANTS IN THE BISPHOSPHOGLYCERATE MUTASE GENE by M. J. van Dijk, B. A. van Oirschot, M. C. Stam-Slob, B. van der Zwaag, E. J. van Beers, J. J. Jans, P. van der Linden, J. M. Torregrosa Diaz, B. Gardie, F. Girodon, R. Schots, N. Thielen, R. van Wijk

    Published 2022-06-01
    Get full text
    Article
  2. 2
    P1501: FOLLOW-UP RESULTS OF A PHASE 2 STUDY ASSESSING THE SAFETY AND EFFICACY OF MITAPIVAT TREATMENT, AN ORAL PYRUVATE KINASE ACTIVATOR, FOR UP TO 60 WEEKS IN SUBJECTS WITH SICKLE CELL DISEASE

    P1501: FOLLOW-UP RESULTS OF A PHASE 2 STUDY ASSESSING THE SAFETY AND EFFICACY OF MITAPIVAT TREATMENT, AN ORAL PYRUVATE KINASE ACTIVATOR, FOR UP TO 60 WEEKS IN SUBJECTS WITH SICKLE... by M. J. van Dijk, M. A. Rab, B. A. van Oirschot, J. Bos, C. Derichs, A. W. Rijneveld, M. H. Cnossen, E. Nur, B. J. Biemond, M. Bartels, J. J. Jans, W. W. van Solinge, R. E. Schutgens, R. van Wijk, E. J. van Beers

    Published 2022-06-01
    Get full text
    Article
  3. 3
    5589320 FOLLOW-UP RESULTS OF A PHASE 2 STUDY ASSESSING THE SAFETY AND EFFICACY OF MITAPIVAT TREATMENT, AN ORAL PYRUVATE KINASE ACTIVATOR, FOR UP TO 60 WEEKS IN SUBJECTS WITH SICKLE CELL DISEASE

    5589320 FOLLOW-UP RESULTS OF A PHASE 2 STUDY ASSESSING THE SAFETY AND EFFICACY OF MITAPIVAT TREATMENT, AN ORAL PYRUVATE KINASE ACTIVATOR, FOR UP TO 60 WEEKS IN SUBJECTS WITH SICKLE... by M.J. van Dijk, M.A.E. Rab, B.A. van Oirschot, J.F. Bos, C. Derichs, A.W. Rijneveld, M.H. Cnossen, E. Nur, B.J. Biemond, M. Bartels, J.J.M. Jans, W.W. van Solinge, R.E.G. Schutgens, R. van Wijk, E.J. van Beers

    Published 2023-04-01
    Get full text
    Article

Search Tools: